Skip to Content
You are currently on the new version of our website. Access the old version .
VaccinesVaccines
  • Article
  • Open Access

15 August 2022

11 Pages

Homologous or Heterologous COVID-19 Booster Regimens Significantly Impact Sero-Neutralization of SARS-CoV-2 Virus and Its Variants

,
,
,
,
,
,
,
,
…
1
Department of Disease Control, Ministry of Public Health, Nonthaburi 11000, Thailand
2
Department of Virology, Armed Force Research Institute of Medical Sciences, Bangkok 10400, Thailand
3
Thai Red Cross Emerging Infectious Diseases Clinical Center, King Chulalongkorn Memorial Hospital, Bangkok 10330, Thailand
4
Samut Sakhon Provincial Health Office, Ministry of Public Health, Nonthaburi 11000, Thailand

Abstract

We determined the levels of neutralizing antibodies against the SARS-CoV-2 ancestral strain, Delta and Omicron variants of concern (VOCs), in 125 healthcare workers who received CoronaVac as their primary vaccination and later received either a single ChAdOx1 or a combi-nation of two consecutive boosters using either two ChAdOx1 doses or a ChAdOx1 or BNT162b2 as the primary and second boosters, respectively, or two doses of BNT162b2. The titers 12 weeks after primary vaccination were inadequate to neutralize all strains. After a single ChAdOx1 booster, the levels of neutralization at Day 30 varied significantly, with only a small proportion of participants developing neutralizing titers against Omicron at Day 7 and 30. The two doses of ChAdOx1 as the booster induced the lowest activity. A combination ChAdOx1 and BNT162b2 induced greater neutralization than by two doses of ChAdOx1. Two doses of BNT162b2 as the booster had the maximal activity against Omicron VOC.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.